Program of Digital Accompaniment to Optimize Homework Performances and Increase Familial Quality of Life in 9 to 16 Years Children With ADHD (PANDA-H)

November 14, 2023 updated by: Nantes University Hospital

Randomized Controlled Trial for Efficacy Assessment of a Program of Digital Accompaniment to Optimize Homework Performances and Increase Familial Quality of Life in 9 to 16 Years Children With ADHD" - PANDA-H

Attention Deficit Disorder with or without Hyperactivity (ADHD) is a frequent pathology in children that has important consequences on schooling both in terms of academic level (due to the attentional disorder) and behavior (disruption of the class). ADHD also has an impact on family functioning, which can generate stress and family altercations. The homework period can be a particularly tense time and a source of conflict with the child, which has negative consequences on the family atmosphere, learning efficiency and of course academic success.

The investigators wish to evaluate an innovative digital device (a smartphone application) to accompany the child during homework periods.

Study Overview

Status

Active, not recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

264

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Amiens, France
        • Berquin
      • Bordeaux, France
        • Bioulac
      • Lyon, France
        • Fourneret
      • Montpellier, France
        • Purpuer
      • Nantes, France
        • Olivier Bonnot
      • Nice, France
        • Caci
      • Paris, France
        • Delorme
      • Strasbourg, France
        • Schroder
      • Versailles, France
        • Speranza

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

9 years to 16 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients aged 9-16 years old with ADHD assessed by Conners 3 scales
  • Parents and children giving informed consent
  • Patients in follow-up list of participant centers
  • Patients with unchanging care for the last 3 months (medication and therapy)

Exclusion Criteria:

  • Patients with severe psychiatric disease such as schizophrenia, bipolar disorder, or autism spectrum disorders and suicidal behavior (all assessed by Child Behavior Checklist Scale)
  • Patients with no smartphone or not easy access to smartphone (ie patients of social facilities, internship…)
  • Patients with mild to severe mental retardation or that may obviously not be able to use the app
  • Patients included in special program other the Care as Usual (defined in the ADHD French network) in follow-up list.
  • Patients with Methylphenidate treatment or change of titration for less than 3 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pandah Application only
Design is a controlled randomized Study with two parallel arms after randomization with a three months follow-up of the two arms that are (Group 1) Care as usual for patients in follow-up list; (Group 2) PANDAH App proposed alone with only 15-20 minutes setup with investigator at start-up (digital accompaniment only); Patients of the 2 groups will have a three months follow-up period before secondary evaluation and entering into the so-called extension period.
Patients will have an application on their smartphone to help them do their homework
No Intervention: Care as usual
Design is one period of 3 months with 2 parallel groups (with or without application) following by extension period of 3 months with all subject accessing to the application.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The primary objective is to compare Homework Performance in the PANDAH group vs Usual Care Only group in ADHD patients at 3 months.
Time Frame: 3 months
Global score of Homework Performance Questionnaire (HPQ), Parent version at 3 months. • Homework Performance Questionnaire = HPQ Parental and Teacher version are a 27 (Parental) and 25 (teacher) items scale scored form 0 (never) to 3 (very often). Total score is a sum of item's scores. Highest score is the worst. Min : 0 Max 108 (Parental) and 100 (Teacher)
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Homework Performance assessed by Parents collected at 0, 3 and 6 months between the PANDAH group and Usual Care group
Time Frame: 0, 3, 6, Months
Global score and domain scores of Homework Performance Questionnaire (HPQ), Parent version at Month 0, Months 3, and Months 6. • Homework Performance Questionnaire = HPQ Parental and Teacher version are a 27 (Parental) and 25 (teacher) items scale scored form 0 (never) to 3 (very often). Total score is a sum of item's scores. Highest score is the worst. Min : 0 Max 108 (Parental) and 100 (Teacher)
0, 3, 6, Months
Change in Homework Performance assessed by Teachers at 0, 3 and 6 months between the PANDAH group and usual care group in ADHD patients
Time Frame: 0, 3 and 6 months
Global score and domain scores of Homework Performance Questionnaire (HPQ), Teacher version at 0, 3 and 6 months. • Homework Performance Questionnaire = HPQ Parental and Teacher version are a 27 (Parental) and 25 (teacher) items scale scored form 0 (never) to 3 (very often). Total score is a sum of item's scores. Highest score is the worst. Min : 0 Max 108 (Parental) and 100 (Teacher)
0, 3 and 6 months
Change in patient and Family Quality of Life collected at 0, 3 and 6 months between the PANDAH group and Usual Care group.
Time Frame: 0, 3 and 6 months
Patient PedSQL and PedSQL Family Impact Module at 0, 3 and 6 months. • Pediatric Quality of Life Inventory, PedSQL is a 23 items scale in 4 domains (physical capacity, emotion, relationship, and school). Scored from 0(not a problem) to 4 (always a problem). Total score is a sum of item's scores. Highest score is the worst. For children and adolescent. Min O Max 115
0, 3 and 6 months
Change in Homework Problems assessed by Parents at 0, 3 and 6 months between the PANDAH group and Usual Care group in ADHD patients.
Time Frame: 0, 3 and 6 months
Global score of Homework Problem Checklist for Parents at 0, 3 and 6 months. • Homework Problem Checklist = HPC parental version is a 20 items scale scored form 0 (never) to 3 (very often). Total score is a sum of item's scores. Highest score is the worst. Min : 0 Max : 80
0, 3 and 6 months
To evaluate patients' ADHD Core Symptoms in the PANDAH group and Usual Care group in at 0, 3 and 6 months
Time Frame: 0, 3 and 6 months
Inattention and Hyperactivity score of Conners at 0, 3 and 6 months. • Conners scale for parents is a 28 items scale in 3 domains (behavioral disturbances, impulsivity / hyperactivity, and attention disorders). Scored: not at all / a little / a lot / massive (0 to 3). Total score is a sum of item's scores. Highest score is the worst. Min O Max 112
0, 3 and 6 months
To evaluate use/compliance of PANDAH App in the PANDAH group at 6 months and on the whole academic year.
Time Frame: 6 months
In-App score of filling rate and number of complete App sessions during 6 months. • In-App filling rate is the raw data from the smartphone application regarding the usage (number of interactions, duration of activity on each screen and schedule of usage). Score must be appreciated, there is no positive or negative. Scores are variable : number of interaction is O to infiny / Duration to activity is O to infiny and Schedule of usage is time and date.
6 months
To Evaluate patients' Anxiety and Depressive Symptoms in the PANDAH group and Usual Care group at 0, 3 and 6 months
Time Frame: 0, 3 and 6 months
CDRS depression and Hamilton Anxiety at 0, 3 and 6 months. • Child Depression Rating Scale = CDRS is a 17 items scale exploring depression. Items are rated form 1 to 5, 1 to 6 or 1 to 7. Sum of all items make a total score. Highest score is the worst. Min O Max 108
0, 3 and 6 months
To measure global academic efficacy in the PANDAH group and Usual Care group at 3 and 6 months, and/or according PANDAH App use intensity.
Time Frame: 3 and 6 months
Lickert scale addressed to Teachers at 3 and 6 months. • Lickert scale is a analogic scale from 0 to 10 for perceived quality of homework. O is poor and 10 is excellent. Best score is the highest score. Min 0 Max 10
3 and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 11, 2022

Primary Completion (Estimated)

March 15, 2024

Study Completion (Estimated)

March 15, 2024

Study Registration Dates

First Submitted

April 20, 2021

First Submitted That Met QC Criteria

April 22, 2021

First Posted (Actual)

April 23, 2021

Study Record Updates

Last Update Posted (Actual)

November 15, 2023

Last Update Submitted That Met QC Criteria

November 14, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • RC20_0070

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on ADHD

Clinical Trials on Pandah Application smartphone only

Subscribe